Company intelligence / Profile preview

BioClue

Belgium

Ownership: Private
Development stage: Other

Overview

BioClue develops technology for secondary analysis of biological sequences, focusing on read mapping, assembly, and immediate identification of genetic variations, primarily in support of drug discovery and diagnostics. The company’s tools are applied in the fields of molecular diagnostics, drug development, and biological sequence analysis[1].

Modalities: Bioinformatics toolsOmics analytics platforms
Industry: Drug Discovery Services

Beyond the preview

Go deeper on BioClue.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioClue.

Explore the full profile